ORKA — Oruka Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Oruka Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	49.1	53.4	42.4	37.4	376
Prepaid Expenses
Total Other Current Assets
Total Current Assets	50	54.4	42.7	37.6	377
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.449	0.485	0.368	0.257	1.04
Long Term Investments
Other Long Term Assets
Total Assets	50.4	54.9	43.1	37.9	396
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	3.5	3.5	1.13	0.637	13
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.91	3.88	1.41	0.841	13.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	46.5	51	41.7	37	382
Total Liabilities & Shareholders' Equity	50.4	54.9	43.1	37.9	396
Total Common Shares Outstanding
Total Preferred Shares Outstanding